Understanding the regulation of Arg1 and Arg2 in different cell types under consideration of their localization, species-specificity, and multiple biochemical and physiological roles could lead to better pharmacological strategies to target arginase in liver, cardiovascular, hematological, immune/infectious diseases, and cancer. This evidence concerns the gene ARG2 and cancer.